Prism Geo · United States · Texas · Houston · What research is done in Houston?
Research · Houston
What research is done in Houston?
Papers authored at Houston's institutions — The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, The University of Texas Health Science Center at Houston — with the Prism stance layer.
Summary
Houston's institutions are a medical research engine: MD Anderson contributes 6939 papers and Baylor College of Medicine 5980 in the available record. Breast cancer leads opportunity areas with 309, with women's and children's health also prominent.
WATCH Watch whether strong cancer work translates into broader gains across women's and children's health.
What the papers — written in the city and about it — point to, split by the Prism stance layer: work that reads promising versus work that flags problems or urges caution.
Opportunities the research points to
Breast Cancer · 309Women's Health · 212Children's Health · 190Cancer · 188Healthcare · 174Tumor · 164Acute Myeloid Leukemia · 160Neuroscience · 120Machine Learning · 108Mental Health · 105Men's Health · 98Clinical Trials · 83
Concerns the research raises
Healthcare · 206Children's Health · 195Women's Health · 144Breast Cancer · 94COVID-19 · 94Cancer · 94Mental Health · 91Patients' Health · 84Clinical Trials · 74Patient Care · 72Patient Health · 62Research · 46
counts = papers carrying the theme · concerns merge cautionary, critical and problem-identifying work
Institutions
The University of Texas MD Anderson Cancer Center
6,939
Baylor College of Medicine
5,980
The University of Texas Health Science Center at Houston
3,875
University of Houston
3,725
2,904Rice University
187University of Houston - Clear Lake
161University of Houston - Downtown
152Children's Nutrition Research Center at Baylor College of Medicine
146Texas Medical Center
83Banner MD Anderson Cancer Center
Orientation
Promising
7,055
Descriptive
4,714
Breakthrough
4,398
2,510Problem Identifying
1,518Cautionary
1,227Comparative
482Critical
Output by year (sample)
Opportunities (promising + breakthrough)
Breast Cancer · 309Women's Health · 212Children's Health · 190Cancer · 188Healthcare · 174Tumor · 164Acute Myeloid Leukemia · 160Neuroscience · 120Machine Learning · 108Mental Health · 105Men's Health · 98Clinical Trials · 83
Cautions (cautionary + critical)
Children's Health · 60Breast Cancer · 51Healthcare · 50Women's Health · 43Patients' Health · 38Mental Health · 35Patient Health · 29COVID-19 · 29Men's Health · 27Cancer · 23Clinical Trials · 22Patient Care · 22
Problems flagged
Healthcare · 152Children's Health · 135Women's Health · 97Cancer · 71COVID-19 · 65Mental Health · 54Clinical Trials · 52Patient Care · 50Research · 46Patients' Health · 46Breast Cancer · 43Patient Health · 33
Top research topics
Cancer Genomics and Diagnostics · 576Cancer Immunotherapy and Biomarkers · 557CAR-T cell therapy research · 523Lymphoma Diagnosis and Treatment · 454Acute Myeloid Leukemia Research · 448Chronic Lymphocytic Leukemia Research · 377Epigenetics and DNA Methylation · 332RNA modifications and cancer · 321Glioma Diagnosis and Treatment · 319Pancreatic and Hepatic Oncology Research · 286Lung Cancer Treatments and Mutations · 278Immunotherapy and Immune Responses · 249
Most-cited work
Paper
Year
Cited
Orientation
The biology <b>,</b> function <b>,</b> and biomedical applications of exosomes
2020
9903
Promising
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017
8809
Promising
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2018
3936
Promising
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
2022
3466
Descriptive
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
2019
3445
Breakthrough
De novo assembly of the <i>Aedes aegypti</i> genome using Hi-C yields chromosome-length scaffolds
2017
2887
Breakthrough
Detection and localization of surgically resectable cancers with a multi-analyte blood test
2018
2723
Breakthrough
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017
2532
Breakthrough
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023
2472
Critical
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation
2018
2082
Promising
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and…
2017
1991
Descriptive
Global vascular guidelines on the management of chronic limb-threatening ischemia
2019
1820
Breakthrough
Integrated genomic characterization of oesophageal carcinoma
2017
1820
Descriptive
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
2020
1759
Cautionary
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
2020
1572
Critical
figures marked ≈ are scaled estimates from a partial sample · Prism stance layer over 2017+ papers